Cefazolin sodium
(Mfr: SKF)(Conc: 20 mg/mLa)
Hetastarch in sodium chloride 0.9%
(Mfr: DCC)(Conc: 6%)
Remarks:
Simulation in vials showed no incompatibility, but white precipitate formed in Y-site during infusion
Ref:
1315